These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 63184)

  • 21. The use of the urinary excretion of delta-aminolevulinic acid as a criterion for lead absorption in industrial medicine and insurance medicine.
    Lahaye D; Roosels D; Bossiroy JM; van Assche F
    Int Arch Occup Environ Health; 1977 Aug; 39(3):191-8. PubMed ID: 924689
    [No Abstract]   [Full Text] [Related]  

  • 22. [Renal delta-aminolevulinic acid excretion in persons not exposed to lead].
    Massmann W
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie; 1982 Jun; 32(6):210-2. PubMed ID: 7113496
    [No Abstract]   [Full Text] [Related]  

  • 23. [A method for screening of lead exposure using spot urine sample based on relationship between delta-ALA and creatinine excretion (author's transl)].
    Nishima T
    Nihon Eiseigaku Zasshi; 1977 Jun; 32(2):398-405. PubMed ID: 916314
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lead and delta-aminolevulinic acid in urine: quality control].
    Grisler R; Gobbi A; Colombo G; Colombo R; Valla C
    Med Lav; 1974; 65(5-6):202-5. PubMed ID: 4456167
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative determination of urinary delta-aminolevulinic acid as an index of lead exposure by high-performance liquid chromatography.
    Ogata M; Taguchi T
    Ind Health; 1986; 24(4):259-64. PubMed ID: 3818368
    [No Abstract]   [Full Text] [Related]  

  • 26. [Correlation of concentrations of gamma aminolevulinic acid and creatinine in the urine (screening test for lead exposure by urinary spot samples)].
    Kikuchi M; Nishima T
    Nihon Eiseigaku Zasshi; 1975 Apr; 30(1):108. PubMed ID: 1169457
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lead exposure of selected population groups. II. The lead level of the blood and delta-aminolevulinic acid level of the urine in the workers in a modern lead and zinc plant].
    Grabecki J; Jarkowski M; Michalewicz L
    Rocz Panstw Zakl Hig; 1981; 32(5-6):439-47. PubMed ID: 7344057
    [No Abstract]   [Full Text] [Related]  

  • 28. [Blood, urine and water levels of lead and cadmium and urinary delta-aminolevulinic acid levels].
    Roosels D; Bossiroy JM
    Arch Belg Med Soc; 1978 May; 36(5):269-82. PubMed ID: 736552
    [No Abstract]   [Full Text] [Related]  

  • 29. [Behavior of deltaaminolevulinic acid concentration in urine and various hematologic parameters in lead-exposed subjects].
    Heinemann G
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl; 1980 Mar; 30(3):70-4. PubMed ID: 7467900
    [No Abstract]   [Full Text] [Related]  

  • 30. [Aminolcevulinic acid excretion in women before and after delivery and in their newborn infants (authors transl)].
    Maruna RF; Maruna H; Altmann P; Georgiades E; Michalica W
    Wien Klin Wochenschr; 1975 Oct; 87(20):692-5. PubMed ID: 1220271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of lead exposure in a population of children from Lausanne].
    Berode M; Guillemin M; Lejeune M; Bovet P; Lob M
    Helv Paediatr Acta Suppl; 1980 Mar; (43):1-63. PubMed ID: 6161110
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experience with the Grabecki and co-workers method of urinary delta-aminolevulinic acid determination in the prevention of lead intoxication].
    Müller W; Holzapfel G
    Int Arch Arbeitsmed; 1969 Dec; 25(4):287-91. PubMed ID: 5370813
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of some parameters of lead exposure and possible correlation between them.
    Soliman MH; El-Sadek YM; El-Kashlan KM; Gabr Y; El-Waseef A
    J Egypt Med Assoc; 1976; 59(5-6):469-80. PubMed ID: 1032315
    [No Abstract]   [Full Text] [Related]  

  • 34. [Delta-aminolevulinic acid determination (ALA) in lead-exposed workers].
    Jahn O
    Wien Z Inn Med; 1973; 54(4):175-9. PubMed ID: 4763139
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biological monitoring of workers exposed to lead. Usefulness and limitations of indicators of internal dose and early biological effect].
    Alessio L; Bertazzi PA; Cortona G
    Med Lav; 1978; 69(1):4-25. PubMed ID: 349336
    [No Abstract]   [Full Text] [Related]  

  • 36. [Exposure to lead of selected populations. I. Lead, hemoglobin and erythrocyte count in the blood and delta-aminolevulinic acid (ALA) concentration in the urine of school children in the Katowice province].
    Grabecki J; Jarkowski M
    Rocz Panstw Zakl Hig; 1979; 30(1):97-103. PubMed ID: 451420
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary delta-aminolevulinic acid as a biological indicator throughout penicillamine therapy in lead intoxication.
    Molina-Ballesteros G; Zuñiga-Charles MA; Sanchez-Anzaldo FJ; Gonzalez-Ramirez JD
    Arch Environ Health; 1978; 33(6):308-13. PubMed ID: 736614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The measurement of -aminolevulinic acid in urine.
    Vincent WF; Ullmann WW
    Ann Clin Lab Sci (1971); 1972; 2(1):31-6. PubMed ID: 5081899
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of urea on the simple determination of delta-aminolevulinic acid in urine.
    Tomokuni K; Hirai Y
    Ind Health; 1985; 23(4):295-7. PubMed ID: 3833861
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluorimetric determination of urinary delta-aminolevulinic acid by high-performance liquid chromatography and post-column derivatization.
    Okayama A
    J Chromatogr; 1988 Apr; 426(2):365-9. PubMed ID: 3392148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.